Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial
SARS-CoV-2重组刺突蛋白纳米颗粒疫苗在HIV-1感染者和非感染者中的免疫原性和安全性:一项随机、对照、2A/2B期试验
期刊:Lancet HIV
影响因子:13
doi:10.1016/S2352-3018(22)00041-8
Madhi, Shabir A; Moodley, Dhayendre; Hanley, Sherika; Archary, Moherndran; Hoosain, Zaheer; Lalloo, Umesh; Louw, Cheryl; Fairlie, Lee; Fouche, Leon Frederik; Masilela, Mduduzi S L; Singh, Nishanta; Grobbelaar, Coert; Ahmed, Khatija; Benadé, Gabriella; Bhikha, Sutika; Bhorat, As'ad Ebrahim; Bhorat, Qasim; Joseph, Natasha; Dheda, Keertan; Esmail, Aliasgar; Foulkes, Sharne; Goga, Ameena; Oommen Jose, Aylin; Kruger, Gertruida; Kalonji, Dishiki J; Lalloo, Natasha; Lombaard, Johan J; Lombard Koen, Anthonet; Kany Luabeya, Angelique; Mngqibisa, Rosie; Petrick, Friedrich G; Pitsi, Annah; Tameris, Michele; Thombrayil, Asha; Vollgraaff, Pieter-Louis; Cloney-Clark, Shane; Zhu, Mingzhu; Bennett, Chijioke; Albert, Gary; Faust, Emmanuel; Plested, Joyce S; Fries, Lou; Robertson, Andreana; Neal, Susan; Cho, Iksung; Glenn, Greg M; Shinde, Vivek
SARS-CoV-2
HIV
炎症/感染
微生物学
免疫/内分泌